Portable Impedance Sensor for Sickle Cell Vascular Occlusion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monitoring vascular occlusion in sickle cell disease are inadequate, as they lack portable, automated, and quantitative tools for detecting vascular obstruction by rigid sickle cells, which complicates patient management and therapeutic outcome evaluation.
Innovation Solution
A portable, automated device with a microfluidic chip mimicking blood microvasculature and an integrated electrical impedance sensor for real-time measurement of sickle cell traversal through capillary-like structures, allowing direct observation of vascular obstruction and the effects of anti-sickling drugs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If existing laboratory techniques (hemoglobin electrophoresis, HPLC) are used for SCD diagnosis, then diagnostic accuracy is improved, but device complexity and ease of operation deteriorate due to sophisticated equipment and complicated procedures
Solution Approach 1:
The patent creates a simplified microfluidic model that copies the essential features of human microvasculature (capillary networks with endothelial cells, pericytes, and basement membrane) to study vaso-occlusion. This model copy allows complex physiological processes to be observed in a simplified, portable device without requiring full-scale laboratory equipment
Solution Approach 2:
The patent replaces complex mechanical laboratory equipment (centrifuges, HPLC systems, electrophoresis apparatus) with a microfluidic system that uses passive flow control and integrated sensors. The microfluidic chip replaces multiple mechanical components with a single integrated platform that performs sampling, analysis, and detection
2Ease of operation
If portable point-of-care devices are developed for SCD diagnosis, then ease of operation and portability are improved, but measurement precision for vascular occlusion monitoring deteriorates
Solution Approach 1:
The patent embeds multiple functional components within the microfluidic chip including endothelial cell-lined channels, pericyte structures, sickle cell samples, and impedance sensors nested within a single portable device. This nested architecture allows complex diagnostic capabilities to be contained in a compact, portable format
Solution Approach 2:
The patent introduces an electrical impedance sensor as an intermediary that indirectly measures vascular occlusion by detecting changes in electrical properties of blood flow through the microvasculature. This intermediary measurement approach enables accurate occlusion detection without requiring direct visualization or complex imaging equipment
3Productivity
If automated monitoring of vascular occlusion is implemented, then productivity and timely intervention are improved, but device complexity worsens
Solution Approach 1:
The patent implements self-service automation where the microfluidic system automatically performs sample processing, cell separation, and occlusion assessment without requiring manual intervention at each step. The system self-regulates flow rates, automatically analyzes impedance changes, and provides real-time occlusion metrics
Solution Approach 2:
The patent merges multiple functions (sample processing, microvascular model, impedance sensing, data analysis) into a single integrated microfluidic platform. This consolidation reduces device complexity by eliminating the need for separate automated systems for each function while maintaining high monitoring productivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables direct and quantitative monitoring of vascular occlusion, facilitating timely intervention and improving patient management by providing real-time data on vaso-occlusive crises and therapeutic responses.
Implementation Method 1
an impedance sensor, which can be used for real-time measurement of sickle cell traversal through the microvasculature and for blood flow and occlusion detection
Data Source
AI summary
An exemplary portable automated device is developed for in vitro testing of blood vascular occlusion as a result of sickle cell disease. The portable automated device may be controlled by a computer (e.g., smartphone) application. Calibration of the portable device may be performed using a component of known impedance value. With the developed portable automated device, analysis may be performed on sickle cell samples on a microfluidic platform that mimics the structure of human capillaries. Significant differences in cell impedance signals may be observed between sickle cells and normal cells, as well as between sickle cells under hypoxia and normoxia conditions.